Department of Nuclear Medicine, Seth G.S. Medical College and K.E.M Hospital, Mumbai.
Department of Radiology, Division of US, CT and MRI, Peripheral Vascular Laboratory, North Shore - Long Island Jewish Health System.
Radiol Clin North Am. 2024 Nov;62(6):1035-1062. doi: 10.1016/j.rcl.2024.07.010. Epub 2024 Sep 11.
Intravenous contrast-enhanced ultrasound (CEUS) is a rapidly evolving imaging technique that uses a microbubble contrast agent to enhance ultrasonographic images by augmenting characterization of blood vessels and organ perfusion. CEUS is considered as a useful problem-solving tool and as an indicated first-line imaging modality in select settings. CEUS technique has an inherent advantage over its predecessor B-mode and Doppler imaging. This article reviews different approved and off-label use of CEUS in the pediatric and adult population and also discusses Food and Drug Administration-approved contrast agents in the United States, their reported side effects, and ongoing efforts in the field.
静脉内超声造影（CEUS）是一种快速发展的成像技术，它使用微泡造影剂通过增强血管和器官灌注的特征来增强超声图像。CEUS 被认为是一种有用的解决问题的工具，并且在某些情况下是首选的一线成像方式。CEUS 技术相对于其前身 B 模式和多普勒成像具有内在优势。本文回顾了 CEUS 在儿科和成人中的不同批准和非适应证用途，还讨论了美国食品和药物管理局批准的造影剂、它们的报告副作用以及该领域正在进行的努力。
